These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 22535624)

  • 21. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies.
    Espinel-Ingroff A; Johnson E; Hockey H; Troke P
    J Antimicrob Chemother; 2008 Mar; 61(3):616-20. PubMed ID: 18222957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
    Castanheira M; Duncanson FP; Diekema DJ; Guarro J; Jones RN; Pfaller MA
    Antimicrob Agents Chemother; 2012 Jan; 56(1):352-7. PubMed ID: 22083469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
    Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Buitrago MJ; Monzon A; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2006 Mar; 50(3):917-21. PubMed ID: 16495251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
    Rudramurthy SM; Chakrabarti A; Geertsen E; Mouton JW; Meis JF
    Diagn Microbiol Infect Dis; 2011 Dec; 71(4):370-7. PubMed ID: 21937186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
    Johnson EM; Szekely A; Warnock DW
    J Antimicrob Chemother; 1998 Dec; 42(6):741-5. PubMed ID: 10052897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
    Rudramurthy SM; Jatana M; Singh R; Chakrabarti A
    Mycoses; 2013 Jan; 56(1):39-46. PubMed ID: 22519679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
    Philip A; Odabasi Z; Rodriguez J; Paetznick VL; Chen E; Rex JH; Ostrosky-Zeichner L
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3572-4. PubMed ID: 16048988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Fothergill A; Ghannoum M; Manavathu E; Ostrosky-Zeichner L; Pfaller M; Rinaldi M; Schell W; Walsh T
    J Clin Microbiol; 2005 Oct; 43(10):5243-6. PubMed ID: 16207990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections.
    Castanheira M; Messer SA; Jones RN; Farrell DJ; Pfaller MA
    Int J Antimicrob Agents; 2014 Oct; 44(4):320-6. PubMed ID: 25129315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of antifungals against Zygomycetes.
    Alastruey-Izquierdo A; Castelli MV; Cuesta I; Zaragoza O; Monzón A; Mellado E; Rodríguez-Tudela JL
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():71-6. PubMed ID: 19754762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
    Marangon FB; Miller D; Giaconi JA; Alfonso EC
    Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Revised Species Concept for Opportunistic
    Wagner L; de Hoog S; Alastruey-Izquierdo A; Voigt K; Kurzai O; Walther G
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin.
    Wildfeuer A; Seidl HP; Paule I; Haberreiter A
    Mycoses; 1998; 41(7-8):309-19. PubMed ID: 9861837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections.
    Carrillo-Muñoz AJ; Quindós G; Ruesga M; Alonso R; del Valle O; Hernández-Molina JM; McNicholas P; Loebenberg D; Santos P
    J Antimicrob Chemother; 2005 Mar; 55(3):317-9. PubMed ID: 15705637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
    Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.
    Spreghini E; Orlando F; Giannini D; Barchiesi F
    J Antimicrob Chemother; 2010 Oct; 65(10):2158-63. PubMed ID: 20667887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
    Pfaller MA; Carvalhaes CG; Messer SA; Rhomberg PR; Castanheira M
    Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115473. PubMed ID: 34352433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
    Wildfeuer A; Seidl HP; Paule I; Haberreiter A
    Arzneimittelforschung; 1997 Nov; 47(11):1257-63. PubMed ID: 9428984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes.
    Sun QN; Fothergill AW; McCarthy DI; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 2002 May; 46(5):1581-2. PubMed ID: 11959605
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Samaddar A; Mendonsa JM; Sudhaharan S; S N; Kindo AJ; Shetty A; Pamidimukkala U
    Microbiol Spectr; 2024 Aug; 12(8):e0078124. PubMed ID: 38920376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.